MedTrace Logo

Pilot Study on Intra-abdominal Photodynamic Diagnosis in Peritoneal Carcinosis

NCT02840331 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-10-27

No results posted yet for this study

Summary

The study would examine by hypericin-supported Fluoreszenzlaparoskopy in terms of tumor size, number and location of the combination of photodynamic diagnosis (PDD) and therapy (PDT) with regard to the detection of peritoneal metastases of locally advanced gastric cancer at 50 adult patients.

Conditions

  • Peritoneal Carcinomatosis

Interventions

DRUG

St. John's Wort

Single oral doses (900 milligram) 2-4 hours before laparoscopy

DEVICE

Photodynamic diagnostic and therapy

Intraoperative irradiation with light (photodynamic diagnosis (PDD) and therapy (PDT), with the appropriate wavelength (390-440 nanometer) over 15 minutes

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Stefan Beckert, Prof. Dr. · University Department of General, Visceral and Transplant Surgery

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-31
Primary Completion
2019-12-31
Completion
2020-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02840331 on ClinicalTrials.gov